AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Future of Stenosis
Stenotrophomonas is the final organism to be examined in this week's M100. Tykar: We're trying at primsilphamethoxazole, which has a breakpoint of less than or equal to two slash 38. But we would all also agree that there's really no consensus on what dose to give and that trying to model this drug is very challenging.